Cure My Disease

Don't miss your cure!

 Log in / Sign up

VR offers calm for kids facing serious illness

NCT ID NCT06915883

Symptom relief Sponsor: National Institute of Mental Health, Czech Republic Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether virtual reality (VR) can help reduce anxiety in children aged 7 to 17 with life-limiting or life-threatening conditions. Fifty children tried two types of VR—one experiential and one relaxation—for 7 to 15 minutes each. Researchers measured their anxiety, pain, and fear before and after the VR sessions to see if it made a difference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Dec 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

7 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age 7-17.9 years * sufficient level of contact with the environment and ability to cooperate * children and parents fluent in Czech * diagnosis of a life-threatening or life-limiting disease according to the internationally accepted list of palliatively relevant diagnoses * pediatric patients treated at the University Hospital Motol Exclusion Criteria: * age below 7 or above 17.9 years * unstable health status * inability to speak Czech * absence of parental consent for participation in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Life limiting conditions are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Life limiting conditions Life threatening diseases Pediatric palliative care

Contacts and locations

Locations

  • University Hospital Motol

    Prague, Czech Republic, 15006, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.